No Detail Found!

Assessment of Public Interest in the Use of Munjaro for Weight Loss in Ha'il City Community, KSA

Author(s)
Ebtehaj Saud Almughais Department of Family and Community Medicine, College of Medicine, University of Hail, Hail, Saudi Arabia
Fatmah Fahad Alreshidi Department of Family and Community Medicine, College of Medicine, University of Hail, Hail, Saudi Arabia
Atheer Yaser M. Alraddadi College of Medicine, University of Hail, Hail, Saudi Arabia
Shuruq Radhi Ali Alrashdi College of Medicine, University of Hail, Hail, Saudi Arabia
Salihh Saalih M. Alrashidi College of Medicine, University of Hail, Hail, Saudi Arabia
Motab Mohammad S. Alreshidi College of Medicine, University of Hail, Hail, Saudi Arabia
Razan Saleh S. Alanazi College of Medicine, University of Hail, Hail, Saudi Arabia
Yara Majed Aljerwan College of Medicine, University of Hail, Hail, Saudi Arabia
Fahmida Khatoon Department of Biochemistry, College of Medicine, University of Hail, Hail, Saudi Arabia
Bashayr S. Almarzooq Department of Family and Community Medicine, College of Medicine, University of Ha’il, Hail, 2440, Saudi Arabia
Abstract
Background: Obesity has become a critical public health challenge in Saudi Arabia, driving growing interest in pharmacological weight-management options, including off-label use of GLP-1-based therapies such as tirzepatide (Mounjaro). This study aimed to assess public knowledge, perceptions and interest in Mounjaro among adults in Ha'il, focusing on awareness sources, perceived effectiveness, safety concerns, eligibility criteria and understanding of FDA approval status. Methods: A crosssectional electronic survey was distributed via social media platforms between December 2024 and February 2025, yielding responses from approximately 200 participants. Data were analysed using SPSS version 27, employing descriptive statistics and Chi-square tests with a significance threshold of p<0.05. Results: The findings revealed high general awareness of Mounjaro (93%), with healthcare staff, family and social media serving as the primary information sources. Despite broad awareness, detailed knowledge remained limited, as 48% reported low and 25% no knowledge of the medication. Most participants perceived Mounjaro as effective for weight loss (92.5%) and were familiar with common side effects such as nausea and vomiting. Education level and knowledge significantly influenced the likelihood of consulting a doctor, while gender differences showed higher awareness among females. A strong majority (88%) expressed a need for increased public education. Conclusion: These results highlight widespread interest but insufficient understanding of Mounjaro, emphasizing the need for targeted awareness campaigns and evidence-based health communication strategies.
Publication Details
Page(s) 129-136
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 11, Year: 2025

Request the full text from PASTIC

Keywords
weight management, Mounjaro, Saudi Arabia, Public awareness, tirzepatide
References
Camacho Andreas,Ruppel Andreas .2017 .“Is the calorie concept a real solution to the obesity epidemic?” Global Health Action. , 1289650(1) : .
Risk Factor Collaboration NCD .2016 .Trends in adult bodymass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. The Lancet, 387(10026) : 1377.
Denicola . .Obesity and public health in the Kingdom of Saudi Arabia. Reviews on Environmental Health, 30(2015) : 191-205.
Al-Ghamdi . .Prevalence of overweight and obesity based on the body mass index: A cross-sectional study in Alkharj, Saudi Arabia. Lipids in Health and Disease, 17(2018) : 134.
Obesity Federation World,Reports Country .2020 .Obesity: Missing the 2025 Global Targets. , : .
Guh Daphne P. . .The incidence of co-morbidities related to obesity and overweight: A systematic review and metaanalysis. ” BMC Public Health, 9(2009) : 88.
Hendricks .2017 .Off-label drugs for weight management. ” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, : 223-234.
Rabkin S. W. . .Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: A systematic review and meta-analysis. ” Obesity Reviews, 16(2015) : 406-415.
Sabrina H . .Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: A Google Trends analysis. ” Aesthetic Surgery Journal, 44(2024) : 60-67.
Chavda Vivek P. .2022 .Tirzepatide, a new era of dualtargeted treatment for diabetes and obesity: A mini-review. ” Molecules, 27(13) : 4315.
Alshaikh .2022 .Clinical practice guideline for the management of overweight and obesity in adults in Saudi Arabia. International Journal of Clinical Medicine, 13(12) : 590-649.
Alfadda .2016 .The Saudi clinical practice guideline for the management of overweight and obesity in adults. Saudi Medical Journal, 37(10) : 1151.
Abutaima .2023 .Jordanian population knowledge, attitude and practices on the uses of antidiabetics for weight loss purposes: A cross sectional study. , : .
Algarni .2023 .Knowledge and attitude of the general population in Saudi Arabia toward weight management medications (WMMs): A cross-sectional study. ” Cureus, 15(8) : .
Alshehri S.,December S. .2025 .Usage and perception of new parenteral medications for weight loss in Saudi Arabia. Bahrain Medical Bulletin, 45(4) : .
Farzam Preeti,Patel Preeti .2024 .. , : .
Algamdi .2022 .Knowledge, attitude and practice level of using diabetes medication to lose weight for non-diabetic patients. ” Archives of Pharmacy Practice, 13 : 55-62.
Zalat ,Marwa M. . .Assessment of awareness toward glsucagon-like peptide-1 anti-diabetic medication in Madinah City, Saudi Arabia: A cross-sectional study. Saudi Journal of Medical and Pharmaceutical Sciences, 11(2025) : 534-539.
Sabrina H . .Practice patterns and perspectives of the off-label use of GLP-1 agonists for cosmetic weight loss. ” Aesthetic Surgery Journal, 44(2024) : NP279-NP306.
Turnock .2025 .Off-label GLP-1 weight-loss medicine use among online bodybuilders: Folk pharmacology, risk and harm reduction. International Journal of Drug Policy, 142 : 104854.
0

Citations

0

Downloads

13

Views